VTUS Related Analyst Ratings
-
Ventrus Biosciences (VTUS) Trading Near Cash Value Says Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades Ventrus Biosciences (VTUS) to Buy as Oct. Catalysts Loom
-
Cantor Fitzgerald Cuts Rating and Price Target Ventrus Biosciences (VTUS); Phase III Trial Misses; New Exit Strategy Potential Sale
-
Brean Murray Carret & Co. Starts Ventrus Biosciences (VTUS) at Buy; Strong Clinical Data Weeks Away
-
Cantor Fitzgerald Starts Ventrus Biosciences (VTUS) at Buy; N-T Binary Play
-
William Blair Starts Ventrus Biosciences (VTUS) at Outperform
-
UPDATE: Leerink Swann Initiates Coverage on Ventrus Bioscience (VTUS) at Outperform, Strong Pipeline
-
Lazard Capital Starts Ventrus Biosciences (VTUS) at Buy
-
Leerink Swann Starts Ventrus Biosciences (VTUS) at Outperform
-
Rodman & Renshaw Starts Ventrus Biosciences (VTUS) at Market Outperform
-
National Securities Starts Ventrus Biosciences (VTUS) at Buy
Back to VTUS Stock Lookup
